John B. Jones on November 1, 2026 7:41 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Amelia Y. Thomas on November 1, 2026 7:42 pm Exploration results look promising, but permitting will be the key risk. Reply
Liam F. Thompson on November 1, 2026 7:43 pm Interesting update on Can Breast Implants Save Your Life?. Curious how the grades will trend next quarter. Reply
Patricia N. Jones on November 1, 2026 7:43 pm Production mix shifting toward Videos might help margins if metals stay firm. Reply
William Brown on November 1, 2026 7:44 pm I like the balance sheet here—less leverage than peers. Reply
Noah Johnson on November 1, 2026 7:44 pm Nice to see insider buying—usually a good signal in this space. Reply
Amelia Moore on November 1, 2026 7:45 pm Interesting update on Can Breast Implants Save Your Life?. Curious how the grades will trend next quarter. Reply
Lucas O. Jackson on November 1, 2026 7:46 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Isabella White on November 1, 2026 7:47 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
John Martin on November 1, 2026 7:49 pm If AISC keeps dropping, this becomes investable for me. Reply
Elizabeth Q. Jackson on November 1, 2026 7:49 pm I like the balance sheet here—less leverage than peers. Reply
Ava Davis on November 1, 2026 7:49 pm Interesting update on Can Breast Implants Save Your Life?. Curious how the grades will trend next quarter. Reply
Ava Williams on November 1, 2026 7:50 pm Silver leverage is strong here; beta cuts both ways though. Reply
Robert Brown on November 1, 2026 7:51 pm I like the balance sheet here—less leverage than peers. Reply
William O. Moore on November 1, 2026 7:52 pm Nice to see insider buying—usually a good signal in this space. Reply
Mary I. Garcia on November 1, 2026 7:53 pm Interesting update on Can Breast Implants Save Your Life?. Curious how the grades will trend next quarter. Reply
Emma Johnson on November 1, 2026 7:53 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Lucas Garcia on November 1, 2026 7:53 pm Production mix shifting toward Videos might help margins if metals stay firm. Reply
Liam J. Smith on November 1, 2026 7:54 pm Nice to see insider buying—usually a good signal in this space. Reply
Patricia Jones on November 1, 2026 7:54 pm If AISC keeps dropping, this becomes investable for me. Reply
Elizabeth U. Miller on November 1, 2026 7:55 pm Interesting update on Can Breast Implants Save Your Life?. Curious how the grades will trend next quarter. Reply
Michael Thomas on November 1, 2026 7:55 pm Silver leverage is strong here; beta cuts both ways though. Reply
Jennifer L. Hernandez on November 1, 2026 8:22 pm Good point. Watching costs and grades closely. Reply
Olivia Moore on November 1, 2026 7:55 pm Nice to see insider buying—usually a good signal in this space. Reply
Michael Hernandez on November 1, 2026 7:55 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
By Garand Thumb
By Garand Thumb
By Garand Thumb
46 Comments
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Interesting update on Can Breast Implants Save Your Life?. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Production mix shifting toward Videos might help margins if metals stay firm.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Interesting update on Can Breast Implants Save Your Life?. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Interesting update on Can Breast Implants Save Your Life?. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Nice to see insider buying—usually a good signal in this space.
Interesting update on Can Breast Implants Save Your Life?. Curious how the grades will trend next quarter.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Production mix shifting toward Videos might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
If AISC keeps dropping, this becomes investable for me.
Interesting update on Can Breast Implants Save Your Life?. Curious how the grades will trend next quarter.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.